- Constellation Brands‘ Q2 Comparable EPS outperformed expectations, reporting $3.74 compared to estimates of $3.53.
- Comparable net sales reached $2.63 billion, marking a 6.1% increase year-on-year, surpassing the $2.53 billion estimate.
- Beer net sales were $2.47 billion, exceeding the $2.4 billion estimate.
- Wine and spirits net sales amounted to $159.4 million, outperforming the $137.6 million estimate.
- Comparable operating profit was $897 million, reflecting a 1.2% yearly increase, above the estimated $872.3 million.
- Beer operating income increased by 1.3% year-on-year, totaling $964.2 million against an estimated $924.6 million.
- Wine & Spirits operating income reversed to $6.10 million from a $19.8 million loss the previous year, against an expected loss of $2.51 million.
- Beer shipment volumes grew by 5.5%, compared to an estimate of 2.09% growth.
- Wine and Spirits shipment volume surged by 15.4%, contrary to an expected decline of 0.4%.
- The forecast for 2027 maintains a comparable EPS of $11.20 to $11.90.
- The forecast anticipates flat to 1% growth in net sales and beer sales, and wine and spirits net sales change of -1% to 1%.
- Expected operating cash flow is between $2.4 billion and $2.5 billion, slightly below the $2.55 billion estimate.
- Forecasted free cash flow is $1.6 billion to $1.7 billion, aligning closely with a $1.7 billion estimate.
- Capital expenditure is projected to be around $800 million, aligning with the $793.7 million estimate.
- Constellation Brands declared a quarterly cash dividend of $1.03 per share.
- The company acquired the spirit-based ready-to-drink brand Spikedade, involving a $75 million initial payment and up to $278 million in contingent payments over five years.
- The company’s current market consensus includes 14 buy ratings, 9 hold ratings, and 2 sell ratings.
Constellation Brands on Smartkarma
Constellation Brands is under the spotlight on Smartkarma, with insights provided by Baptista Research. In their report titled “Constellation Brands Isn’t Just Selling Beer—It’s Tracking A Key U.S. Demographic!”, the analysts delve into the company’s recent performance. The report highlights that the stock surged more than 8% following a positive quarterly report, but the real significance lies in the company’s observations on Hispanic consumer behavior. With about half of Constellation Brands‘ beer business linked to Hispanic consumers, recent trends in this demographic carry significant weight as an indicator of U.S. consumer health. This report sheds light on the importance of monitoring brand and regional trends to gauge the pulse of a key consumer segment.
A look at Constellation Brands Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Constellation Brands, Inc., a company with a diverse portfolio of alcoholic beverage brands across multiple regions, has received a favorable long-term outlook based on its Smartkarma Smart Scores. With a strong Growth score of 5, the company seems poised for expansion and development within the industry. Additionally, a respectable Dividend score of 4 suggests a commitment to rewarding shareholders, potentially making it an attractive pick for income investors. While the Value and Resilience scores sit at a moderate 3, indicating stability and reasonable pricing, the Momentum score of 3 suggests a steady performance in the market.
In summary, Constellation Brands shows promise for the future with an emphasis on growth and dividends, maintaining a strong position in the alcoholic beverages market. With a strategic approach to its diverse brand portfolio and a track record of joint ventures, the company is positioned to capitalize on opportunities in North America, Europe, Australia, and New Zealand.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
